Health Care : Current Reviews

Menorrhagia and Postpartum Haemorrhage (PPH) in Women with Rare Bleeding Disorder

Global Healthcare & Fitness Summit

July 20-22, 2015 San Francisco, USA

Susan Halimeh

Keynote: Health Care: Current Reviews

Abstract:

In women, von Willebrand disease (VWD) is the most common inherited bleeding disorder. Objectively, it is defined as
bleeding that lasts for more than seven days or results in the loss of more than 80 ml of blood per menstrual cycle. The
prevalence of menorrhagia in a woman with a bleeding disorder ranges from 32 to 100%. Postpartum hemorrhage (PPH)
remains one of the leading causes of maternal morbidity and mortality worldwide. A treatment algorithm for severe persistent
PPH was subsequently developed. These include mechanical or surgical maneuvers, i.e., intrauterine balloon tamponade or
hemostatic brace sutures with hysterectomy as the final surgical option for uncontrollable PPH. Pharmacologic options include
hemostatic agents (tranexamic acid), with timely transfusion of blood and plasma products playing an important role in
persistent and severe PPH.

Biography :

Susan Halimeh has completed her medical education in 1997 at the medical school of medicine in Hannover. She is the Medical director of the Gerinnungszentrum
Rhein-Ruhr and the Coagulation Research Centre GmbH in Duisburg, Germany. She has published diverse articles such as: Menorrhagia and Postpartum
Hemorrhage (PPH) in Women with Rare Bleeding Disorder, Thrombosis Research, 2015 Feb, Volume 135, Suppl. 1, S34-S37